» Articles » PMID: 36105089

An Integrative Analysis of DNA Methylation and Gene Expression to Predict Lung Adenocarcinoma Prognosis

Overview
Journal Front Genet
Date 2022 Sep 15
PMID 36105089
Authors
Affiliations
Soon will be listed here.
Abstract

Abnormal DNA methylation of gene promoters is an important feature in lung adenocarcinoma (LUAD). However, the prognostic value of DNA methylation remains to be further explored. We sought to explore DNA methylation characteristics and develop a quantifiable criterion related to DNA methylation to improve survival prediction for LUAD patients. Illumina Human Methylation450K array data, level 3 RNA-seq data and corresponding clinical information were obtained from TCGA. Cox regression analysis and the Akaike information criterion were used to construct the best-prognosis methylation signature. Receiver operating characteristic curve analysis was used to validate the prognostic ability of the DNA methylation-related feature score. qPCR was used to measure the transcription levels of the identified genes upon methylation. We identified a set of DNA methylation features composed of 11 genes (, , , , , , , , , and ). The feature score, calculated based on DNA methylation features, was independent of tumor recurrence and TNM stage in predicting overall survival. Of note, the combination of this feature score and TNM stage provided a better overall survival prediction than either of them individually. The transcription levels of all the hypermethylated genes were significantly increased after demethylation, and the expression levels of 3 hypomethylated proteins were significantly higher in tumor tissues than in normal tissues, as indicated by immunohistochemistry data from the Human Protein Atlas. Our results suggested that these identified genes with prognostic features were regulated by DNA methylation of their promoters. Our studies demonstrated the potential application of DNA methylation markers in the prognosis of LUAD.

Citing Articles

Investigating the clinical significance of OAS family genes in breast cancer: an in vitro and in silico study.

Lu J, Yang L, Yang X, Chen B, Liu Z Hereditas. 2024; 161(1):50.

PMID: 39633486 PMC: 11619215. DOI: 10.1186/s41065-024-00353-9.


Identification of New Prognostic Genes and Construction of a Prognostic Model for Lung Adenocarcinoma.

Chen X, Yu L, Zhang H, Jin H Diagnostics (Basel). 2023; 13(11).

PMID: 37296766 PMC: 10252847. DOI: 10.3390/diagnostics13111914.

References
1.
Xu H, Sun Y, Ma Z, Xu X, Qin L, Luo B . methylation promotes oncogenesis of endometrial carcinoma through LOC134466/hsa-miR-196a-5p/TAC1 axis. Aging (Albany NY). 2018; 10(11):3353-3370. PMC: 6286819. DOI: 10.18632/aging.101644. View

2.
Ikeda K, Shiraishi K, Eguchi A, Shibata H, Yoshimoto K, Mori T . Long interspersed nucleotide element 1 hypomethylation is associated with poor prognosis of lung adenocarcinoma. Ann Thorac Surg. 2013; 96(5):1790-4. DOI: 10.1016/j.athoracsur.2013.06.035. View

3.
Qiu Z, Ji J, Xu Y, Zhu Y, Gao C, Wang G . Common DNA methylation changes in biliary tract cancers identify subtypes with different immune characteristics and clinical outcomes. BMC Med. 2022; 20(1):64. PMC: 8822710. DOI: 10.1186/s12916-021-02197-w. View

4.
Chi Z, Kong C, Wang Z, Wang Z, Liu G, Hu Z . The signaling pathways involved in metabolic regulation and stress responses of the yeast-like fungi Aureobasidium spp. Biotechnol Adv. 2022; 55:107898. DOI: 10.1016/j.biotechadv.2021.107898. View

5.
Yee N . TRPM8 Ion Channels as Potential Cancer Biomarker and Target in Pancreatic Cancer. Adv Protein Chem Struct Biol. 2016; 104:127-155. DOI: 10.1016/bs.apcsb.2016.01.001. View